UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Socioeconomic burden of immune-mediated inflammatory diseases--focusing on work productivity and disability

Journal of rheumatology. Supplement, 2011-11, Vol.88, p.55-61

2011

Volltextzugriff (PDF)

Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities

Journal of rheumatology. Supplement, 2010-05, Vol.85, p.2-10

2010

Volltextzugriff (PDF)

Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study

The Journal of dermatological treatment, 2022-05, Vol.33 (4), p.2317-2324

2022

Volltextzugriff (PDF)

Ixekizumab Results in Persistent Clinical Improvement in Moderate-to-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial

Acta dermato-venereologica, 2020-01, Vol.100 (1), p.adv00006-9

2020

Volltextzugriff (PDF)

Comparison of topical antiaging creams in the management of lateral canthal lines

Journal of cosmetic dermatology, 2020-03, Vol.19 (3), p.694-704

2020

Volltextzugriff (PDF)

The role of inflammation in the pathophysiology of depression: different treatments and their effects

Journal of rheumatology. Supplement, 2011-11, Vol.88, p.48-54

2011

Volltextzugriff (PDF)

Canadian Expert Consensus on the Use of Halobetasol Propionate/Tazarotene Lotion for Plaque Psoriasis

Dermatology and therapy, 2024-07, Vol.14 (7), p.1917-1928

2024

Volltextzugriff (PDF)

Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials

Dermatology and therapy, 2020-06, Vol.10 (3), p.431-447

2020

Volltextzugriff (PDF)

Acitretin Use in Dermatology

Journal of Cutaneous Medicine and Surgery, 2017-11, Vol.21 (3_suppl), p.2S-12S

2017

Volltextzugriff (PDF)

Baseline Characteristics of Canadian Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Journal of cutaneous medicine and surgery, 2023-11, Vol.27 (6), p.594-600

2023

Volltextzugriff (PDF)

Efficacy and safety of proactive treatment with twice-weekly topical Cal/BD foam in patients with plaque psoriasis undergoing HPA-axis testing: a PSO-LONG subgroup analysis

The Journal of dermatological treatment, 2022-05, Vol.33 (4), p.2297-2304

2022

Volltextzugriff (PDF)

Simultaneous Nail and Skin Clearance in Ixekizumab Head-to-Head Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis

Dermatology and therapy, 2022-04, Vol.12 (4), p.911-920

2022

Volltextzugriff (PDF)

Review of Systemic Treatment Options for Adult Atopic Dermatitis

Journal of Cutaneous Medicine and Surgery, 2017-01, Vol.21 (1), p.31-39

2017

Volltextzugriff (PDF)

Skin care and hygiene among healthcare professionals during and after the SARS-CoV-2 pandemic

SAGE Open Medicine, 2021-12, Vol.9, p.20503121211062795-20503121211062795

2021

Volltextzugriff (PDF)

Canadian Patients’ Preferences in Topical Psoriasis Care: Insights From the PROPEL Surveys

Journal of cutaneous medicine and surgery, 2018-09, Vol.22 (5), p.464-471

2018

Volltextzugriff (PDF)

Maintenance of Investigator’s Static Global Assessment Response with Once-Daily Crisaborole in Participants with Mild to Moderate Atopic Dermatitis

Dermatology and therapy, 2024-04, Vol.14 (4), p.875-892

2024

Volltextzugriff (PDF)

Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis

Frontiers in medicine, 2021-09, Vol.8, p.682547-682547

2021

Volltextzugriff (PDF)

Treating to Target(s) With Interleukin-17 Inhibitors

Journal of cutaneous medicine and surgery, 2019-03, Vol.23 (2_suppl), p.3S-34S

2019

Volltextzugriff (PDF)

Leveraging Blockchain Technology for Informed Consent Process and Patient Engagement in a Clinical Trial Pilot

Blockchain in healthcare today, 2021, Vol.4

2021

Volltextzugriff (PDF)

A dose-finding trial with a novel ingenol derivative (ingenol disoxate: LEO 43204) for field treatment of actinic keratosis on full face or 250 cm2 on the chest

The Journal of dermatological treatment, 2017-11, Vol.28 (7), p.652-658

2017

Volltextzugriff (PDF)

Efficacy and safety of adalimumab in patients with plaque psoriasis who have shown an unsatisfactory response to etanercept

Journal of the American Academy of Dermatology, 2010-08, Vol.63 (2), p.228-234

2010

Volltextzugriff (PDF)

Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma

Journal of cutaneous medicine and surgery, 2015-05, Vol.19 (3), p.239-248

2015

Volltextzugriff (PDF)

Non-melanoma Skin Cancer in Canada Chapter 1: Introduction to the Guidelines

Journal of cutaneous medicine and surgery, 2015-05, Vol.19 (3), p.205-215

2015

Volltextzugriff (PDF)

Alefacept is Safe and Efficacious in the Treatment of Palmar Plantar Pustulosis

Journal of cutaneous medicine and surgery, 2007-11, Vol.11 (6), p.202-205

Guenther, Lyn C.

2007

Volltextzugriff (PDF)

Development of a Clinical Pathway for Atopic Dermatitis Patients: A Case-Based Approach

Journal of drugs in dermatology, 2016-12, Vol.15 (12), p.1485

2016

Volltextzugriff (PDF)

1 – 25 von 153

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(139)
Mit Volltextzugriff
(121)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(153)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Socioeconomic burden of immune-mediated inflammatory diseases--focusing on work productivity and disability

Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities

Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study

Ixekizumab Results in Persistent Clinical Improvement in Moderate-to-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial

Comparison of topical antiaging creams in the management of lateral canthal lines

The role of inflammation in the pathophysiology of depression: different treatments and their effects

Canadian Expert Consensus on the Use of Halobetasol Propionate/Tazarotene Lotion for Plaque Psoriasis

Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials

Acitretin Use in Dermatology

Baseline Characteristics of Canadian Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Efficacy and safety of proactive treatment with twice-weekly topical Cal/BD foam in patients with plaque psoriasis undergoing HPA-axis testing: a PSO-LONG subgroup analysis

Simultaneous Nail and Skin Clearance in Ixekizumab Head-to-Head Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis

Review of Systemic Treatment Options for Adult Atopic Dermatitis

Skin care and hygiene among healthcare professionals during and after the SARS-CoV-2 pandemic

Canadian Patients’ Preferences in Topical Psoriasis Care: Insights From the PROPEL Surveys

Maintenance of Investigator’s Static Global Assessment Response with Once-Daily Crisaborole in Participants with Mild to Moderate Atopic Dermatitis

Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis

Treating to Target(s) With Interleukin-17 Inhibitors

Leveraging Blockchain Technology for Informed Consent Process and Patient Engagement in a Clinical Trial Pilot

A dose-finding trial with a novel ingenol derivative (ingenol disoxate: LEO 43204) for field treatment of actinic keratosis on full face or 250 cm2 on the chest

Efficacy and safety of adalimumab in patients with plaque psoriasis who have shown an unsatisfactory response to etanercept

Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma

Non-melanoma Skin Cancer in Canada Chapter 1: Introduction to the Guidelines

Alefacept is Safe and Efficacious in the Treatment of Palmar Plantar Pustulosis

Development of a Clinical Pathway for Atopic Dermatitis Patients: A Case-Based Approach

Suchergebnisse filtern